Comparison of Two 2.45 GHz Microwave Ablation Devices with Respect to Ablation Zone Volume in Relation to Applied Energy in Patients with Malignant Liver Tumours

Purpose: (i) to compare two 2.45 GHz MWA devices with respect to AZV in relation to the applied energy after MWA in patients with hepatocellular carcinoma (HCC) or colorectal liver metastasis (CRLM) and (ii) to identify potential confounders for this relationship. Methods: In total, 102 tumours, 65...

Full description

Bibliographic Details
Main Authors: Simeon J. S. Ruiter, Jamila E. de Jong, Jan Pieter Pennings, Robbert J. de Haas, Koert P. de Jong
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/22/5570
_version_ 1797465716468744192
author Simeon J. S. Ruiter
Jamila E. de Jong
Jan Pieter Pennings
Robbert J. de Haas
Koert P. de Jong
author_facet Simeon J. S. Ruiter
Jamila E. de Jong
Jan Pieter Pennings
Robbert J. de Haas
Koert P. de Jong
author_sort Simeon J. S. Ruiter
collection DOAJ
description Purpose: (i) to compare two 2.45 GHz MWA devices with respect to AZV in relation to the applied energy after MWA in patients with hepatocellular carcinoma (HCC) or colorectal liver metastasis (CRLM) and (ii) to identify potential confounders for this relationship. Methods: In total, 102 tumours, 65 CRLM and 37 HCC were included in this retrospective analysis. Tumours were treated with Emprint (<i>n</i> = 71) or Neuwave (<i>n</i> = 31) MWA devices. Ablation treatment setting were recorded and applied energy was calculated. AZV and tumour volumes were segmented on the contrast-enhanced CT scans obtained 1 week after treatment. The AZV to applied energy <i>R</i>(AZV:E) ratios were calculated for each tumour treatment and compared between both MWA devices and tumour types. Results: <i>R</i>(AZV:E)<sub>EMPRINT</sub> was 0.41 and <i>R</i>(AZV:E)<sub>NEUWAVE</sub> was 0.81, <i>p</i> < 0.001. Moderate correlation between AZV and applied energy was found for Emprint (r = 0.57, <i>R</i><sup>2</sup> = 0.32, <i>p</i> < 0.001) and strong correlation was found for Neuwave (r = 0.78, <i>R</i><sup>2</sup> = 0.61, <i>p</i> < 0.001). <i>R</i>(AZV:E)<sub>CRLM</sub> was 0.45 and <i>R</i>(AZV:E)<sub>HCC</sub> was 0.52, <i>p</i> = 0.270. Conclusion: This study confirms the unpredictability of AZVs based on the applied output energy for HCC and CRLM. No significant differences in <i>R</i>(AZV:E) were observed between CRLM and HCC. Significantly lower <i>R</i>(AZV:E) was found for Emprint devices compared to Neuwave; however, reflected energy due to cable and antenna design remains unclear and might contribute to these differences.
first_indexed 2024-03-09T18:26:29Z
format Article
id doaj.art-7f37a4a59a6640ba8db59a30958e7fd7
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T18:26:29Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-7f37a4a59a6640ba8db59a30958e7fd72023-11-24T07:53:18ZengMDPI AGCancers2072-66942022-11-011422557010.3390/cancers14225570Comparison of Two 2.45 GHz Microwave Ablation Devices with Respect to Ablation Zone Volume in Relation to Applied Energy in Patients with Malignant Liver TumoursSimeon J. S. Ruiter0Jamila E. de Jong1Jan Pieter Pennings2Robbert J. de Haas3Koert P. de Jong4Department of Hepato-Pancreato-Biliary Surgery and Liver Transplantation, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The NetherlandsDepartment of Hepato-Pancreato-Biliary Surgery and Liver Transplantation, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The NetherlandsDepartment of Radiology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The NetherlandsDepartment of Radiology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The NetherlandsDepartment of Hepato-Pancreato-Biliary Surgery and Liver Transplantation, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The NetherlandsPurpose: (i) to compare two 2.45 GHz MWA devices with respect to AZV in relation to the applied energy after MWA in patients with hepatocellular carcinoma (HCC) or colorectal liver metastasis (CRLM) and (ii) to identify potential confounders for this relationship. Methods: In total, 102 tumours, 65 CRLM and 37 HCC were included in this retrospective analysis. Tumours were treated with Emprint (<i>n</i> = 71) or Neuwave (<i>n</i> = 31) MWA devices. Ablation treatment setting were recorded and applied energy was calculated. AZV and tumour volumes were segmented on the contrast-enhanced CT scans obtained 1 week after treatment. The AZV to applied energy <i>R</i>(AZV:E) ratios were calculated for each tumour treatment and compared between both MWA devices and tumour types. Results: <i>R</i>(AZV:E)<sub>EMPRINT</sub> was 0.41 and <i>R</i>(AZV:E)<sub>NEUWAVE</sub> was 0.81, <i>p</i> < 0.001. Moderate correlation between AZV and applied energy was found for Emprint (r = 0.57, <i>R</i><sup>2</sup> = 0.32, <i>p</i> < 0.001) and strong correlation was found for Neuwave (r = 0.78, <i>R</i><sup>2</sup> = 0.61, <i>p</i> < 0.001). <i>R</i>(AZV:E)<sub>CRLM</sub> was 0.45 and <i>R</i>(AZV:E)<sub>HCC</sub> was 0.52, <i>p</i> = 0.270. Conclusion: This study confirms the unpredictability of AZVs based on the applied output energy for HCC and CRLM. No significant differences in <i>R</i>(AZV:E) were observed between CRLM and HCC. Significantly lower <i>R</i>(AZV:E) was found for Emprint devices compared to Neuwave; however, reflected energy due to cable and antenna design remains unclear and might contribute to these differences.https://www.mdpi.com/2072-6694/14/22/5570colorectal liver metastasishepatocellular carcinomathermal ablationmicrowave ablation
spellingShingle Simeon J. S. Ruiter
Jamila E. de Jong
Jan Pieter Pennings
Robbert J. de Haas
Koert P. de Jong
Comparison of Two 2.45 GHz Microwave Ablation Devices with Respect to Ablation Zone Volume in Relation to Applied Energy in Patients with Malignant Liver Tumours
Cancers
colorectal liver metastasis
hepatocellular carcinoma
thermal ablation
microwave ablation
title Comparison of Two 2.45 GHz Microwave Ablation Devices with Respect to Ablation Zone Volume in Relation to Applied Energy in Patients with Malignant Liver Tumours
title_full Comparison of Two 2.45 GHz Microwave Ablation Devices with Respect to Ablation Zone Volume in Relation to Applied Energy in Patients with Malignant Liver Tumours
title_fullStr Comparison of Two 2.45 GHz Microwave Ablation Devices with Respect to Ablation Zone Volume in Relation to Applied Energy in Patients with Malignant Liver Tumours
title_full_unstemmed Comparison of Two 2.45 GHz Microwave Ablation Devices with Respect to Ablation Zone Volume in Relation to Applied Energy in Patients with Malignant Liver Tumours
title_short Comparison of Two 2.45 GHz Microwave Ablation Devices with Respect to Ablation Zone Volume in Relation to Applied Energy in Patients with Malignant Liver Tumours
title_sort comparison of two 2 45 ghz microwave ablation devices with respect to ablation zone volume in relation to applied energy in patients with malignant liver tumours
topic colorectal liver metastasis
hepatocellular carcinoma
thermal ablation
microwave ablation
url https://www.mdpi.com/2072-6694/14/22/5570
work_keys_str_mv AT simeonjsruiter comparisonoftwo245ghzmicrowaveablationdeviceswithrespecttoablationzonevolumeinrelationtoappliedenergyinpatientswithmalignantlivertumours
AT jamilaedejong comparisonoftwo245ghzmicrowaveablationdeviceswithrespecttoablationzonevolumeinrelationtoappliedenergyinpatientswithmalignantlivertumours
AT janpieterpennings comparisonoftwo245ghzmicrowaveablationdeviceswithrespecttoablationzonevolumeinrelationtoappliedenergyinpatientswithmalignantlivertumours
AT robbertjdehaas comparisonoftwo245ghzmicrowaveablationdeviceswithrespecttoablationzonevolumeinrelationtoappliedenergyinpatientswithmalignantlivertumours
AT koertpdejong comparisonoftwo245ghzmicrowaveablationdeviceswithrespecttoablationzonevolumeinrelationtoappliedenergyinpatientswithmalignantlivertumours